Indication
Endometrial Hyperplasia
6 clinical trials
10 products
1 drug
Clinical trial
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaStatus: Not yet recruiting, Estimated PCD: 2028-06-30
Product
ProgestinProduct
Levonorgestrel-releasing IUDClinical trial
The Etonogestrel Contraceptive Implant for Treatment of Endometrial Hyperplasia Without Atypia: A Single-arm, Open-label, Longitudinal Study in a Government Hospital in the PhilippinesStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Product
Etonogestrel implantClinical trial
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaStatus: Not yet recruiting, Estimated PCD: 2029-06-30
Product
SemaglutideDrug
VarlilumabProduct
LNG-IUDClinical trial
Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia: A Non-Inferiority StudyStatus: Withdrawn, Estimated PCD: 2024-10-01
Product
MegestrolProduct
LevonorgestrelClinical trial
Medroxyprogesterone Acetate (MPA) Versus Dydrogesterone for Management of Endometrial Hyperplasia Without AtypiaStatus: Completed, Estimated PCD: 2022-05-14
Product
MedroxyprogesteroneProduct
DydrogesteroneClinical trial
Prospective Clinical Study of Fertility-sparing Treatment With a Membrane-inhibiting Formula Combined With Oral Progestins for Endometrial Carcinoma and Hyperplasia in Childbearing-age WomenStatus: Recruiting, Estimated PCD: 2025-07-31
Product
Megestrol Acetate